Pharmacology
 |
|
21 january 2020 15:03:27 |
| Effects of CYP2C19*2 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorder (Pharmacogenomics) |
|
Tweet Pharmacogenomics, Volume 21, Issue 2, Page 111-123, January 2020. |
| 229 viewsCategory: Genomics, Pharmacology |
 Impact of CYP2C9, VKORC1, ApoE and ABCB1 polymorphisms on stable warfarin dose requirements in elderly Chinese patients (Pharmacogenomics)The emergent phenomenon of aspirin resistance: insights from genetic association studies (Pharmacogenomics) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
